IVI Aflibercept Before and After Phaco in DME. - Trial NCT05731089
Access comprehensive clinical trial information for NCT05731089 through Pure Global AI's free database. This phase not specified trial is sponsored by Al Hadi Hospital and is currently Completed. The study focuses on Diabetic Macular Edema. Target enrollment is 40 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Al Hadi Hospital
Timeline & Enrollment
N/A
Sep 01, 2019
Dec 01, 2022
Primary Outcome
resolving of macular edema
Summary
To study whether or not cataract surgery should be deferred until treating the co-existing
 diabetic macular edema (DME) using intravitreal (IVI) anti-vascular endothelial growth factor
 (anti-VEGF).
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05731089
Non-Device Trial